UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000025901 |
|---|---|
| Receipt number | R000029596 |
| Scientific Title | Placebo-controlled randomized, double-blind study of zaltoprofen for patients with diffuse type tenosynovial giant cell tumor (Pigmented Villonodular Synovitis) and unresectable localized tenosynovial giant cell tumor (tendon sheath giant cell tumor) (Phase II study) |
| Date of disclosure of the study information | 2017/04/01 |
| Last modified on | 2023/01/12 10:30:05 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2017/01/30 14:07:48 | ||
| 2 | Update | 2017/10/18 09:03:16 | Recruitment status Anticipated trial start date |
|
| 3 | Update | 2017/10/18 17:10:12 | Key inclusion criteria Key inclusion criteria |
|
| 4 | Update | 2018/01/25 20:33:11 | Co-sponsor Co-sponsor |
|
| 5 | Update | 2018/04/23 23:38:57 | Research ethics review |
|
| 6 | Update | 2019/10/31 17:47:01 | Recruitment status Date of IRB Last follow-up date |
|
| 7 | Update | 2023/01/12 10:22:27 | Recruitment status |
|
| 8 | Update | 2023/01/12 10:25:14 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
| 9 | Update | 2023/01/12 10:29:19 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
| 10 | Update | 2023/01/12 10:30:05 | Recruitment status |
